+A A-

M.D. Professor of Medicine Andaç Argon

Name
Andaç Argon
Title
M.D. Professor of Medicine
Phone
E-Mail
medicanaipc@medicana.com.tr

Hospital: Medicana Kadıkoy Hospital, Istanbul


Department: Medical Oncology


Academic Title: Professor of Medicine


Physician Name: Andaç Argon, M.D. Professor of Medicine


Education: Bachelor's Degree: Faculty of Medicine - Istanbul University, Istanbul Faculty of Medicine (1987)

 

Minor: Medical Oncology Specialist, Istanbul University, Institute of Oncology, Department of Medical Oncology (2001)

 

Associate Professor: (29.04.2005)

 

Professor: (10.05.2013)

 

Area of Expertise: Medical Oncology

 

Lung Cancer

 

Breast Cancer

 

Digestive System Cancers

 

Memberships: Turkish Medical Oncology Association

 

American Society of Clinical Oncology (ASCO)

 

European Society of Medical Oncology (ESMO)

 

International Association for the Study of Lung Cancer (IASLC)

 

Association of Lung Cancer (AKAD)

 

Research and Publications: A. The articles published in internationally eminent journals:

 

A1. Andac, Mert B, Sevil B, Burak S, Haluk O. Andac, Mert B, Sevil B, Burak S,

Haluk O. Adult primary extragonadal germ cell tumors: Treatment results and long-term follow-up.

Med Pediatr Oncol. 2003 Jul; 41 (1): 49-53

 

A2. Sakar B, Karagol H, Gumus M, Basaran M, Kaytan E, Argona, Ustuner Z, Bavbek SE,Bugra D, Aykan FN. Timing of death from tumor recurrence after curative gastrectomy  for gastric cancer. Am J Clin Oncol. 2004 Apr; 27 (2): 205-9.

 

A3. Topuz E, Basaran M, Saip P, Aydinere, Argon A, Sakar B, Tas F, Uygun K, Bugra D, Aykan NF. Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5- fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study. Am J Clin Oncol. 2002 Dec; 25 (6): 619-24.

 

A4. Alici S, Eralp Y, Saip P, Argona, Basaran M, Topuz E, Aydiner A. Clinical characteristics of gestational trophoblastic disease at a single institute. Tohoku J Exp Med. 2002 Jun; 197 (2): 95-100.

 

A5. Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Clouds G, Camlica H, Aydiner A, Topuz E. Anemia in oncology practice: in relation to diseases and their therapies.Am J Clin Oncol. 2002 Aug; 25 (4): 371-9.

 

A6. Argona, Aydinera, Tas F, Saip P, Topuz E. Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome. Gynecol Oncol. 2002 May; 85 (2): 362-4.

 

A7. Alici S, Bavbek SE, Eralp Y, Argona A, Basaran M, Aydinere A, Tuzlali S, Topuz E, Onat H. An atypical presentation of metastatic gestational choriocarcinoma with maxillary sinus and subcutaneous involvement; report of a case with literature review. 2002 Oct-Dec; 7 (4): 373-6.

 

A8. Argon A, Basaran M, Yaman F, Dizdar Y, Sakar B, Camlica H, Bavbek SE, Ozger H, Darendeliler E, Onat H. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local

treatment.jpnjclinoncol.2004nov; 34 (11): 667-72.

 

A9. Tas F, Duranildiz D, Argon A, Oguz H, Camlica H, Yasasever V, Topuz E. Serum bcl-2 and survivin levels in melanoma. Melanoma Res. 2004 Dec; 14 (6): 543-6.

 

A10. Tas F, Hansel H, Belce A, Ilvan S, Argon A, Camlica H, Topuz E. Oxidative stress in

breast cancer. Med Oncol. 2005; 22 (1): 11-5.

 

A11. Tas F, Oguz H, Argon A, Duranyildiz D, Camlica H, Lawyer V, Topuz E. The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma.MedOncol. 2005; 22 (3): 241- 6.

 

A12.Tas F, Duranildiz D, Argon A, Oguz H, Camlica H, Casein V, Topuz E. Apoptosis of lymphocytes in peripheral blood of patients with melanoma.

medoncol.2005; 22 (2): 177-81.    

 

A13. Tas F, Duranildiz D, Argon A, Oguz H, Camlica H, Yasasever V, Topuz E. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.medoncol.2005; 22 (4): 353-8.

 

A14. Tas F, Argon A, Camlica H, Topuz E. Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial.Melanoma Dec.2005; 15 (6): 543-8.

 

A15. Tas F, Argon A, Disci R, Topuz E. Pattern and outcome of admission to a medical oncology inpatient service.J Cancer Educ.2007 Summer; 22 (2): 80-5.

 

A16. Sakar B, Gumus M, Basaran M, Argona, Ustuner Z, Ustaoglu MA, Saglam S, Guney N, Tenekeci AN, Aykan NF. XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer.Oncology 2007; 73 (5-6): 298-304. Epub 2008 May 14.

 

A17. Gokdemir G, Argon A, Sakiz D, Argon D, Angle A. Granulomatous slack skin: report of a case with response to electron beam therapy.Med. Oncol.2008; 25 (2): 178-81. Epub 2007 Oct

 

A18. Demir, MK, Fakir, E, Furuncuoglu, Y, Alici, S, Argon, A, Koca, S. Synovial sarcoma with multiple vertebrae metastases causing multilevel thoracic spinal cord compressions pine J. 2016 Jun; 16 (6): e363-4. doi: 10.1016 / J.Spinee.2015.11.063. Epub 2015 Dec 8

 

A19. AU Cirak, Y, Furuncuoglu, Y, Yapicier, O, Argon, A, Alici, S. T. Predictive value of BubR1 and synuclein-gamma expression in breast cancer. Int J Clin Exp Pathol. May 1, 8 (5): 5345-53. eCollection 2015